← Back to Search

Peer Support Intervention for COVID-19 Related Mental Health Issues (RIWP+ Trial)

N/A
Waitlist Available
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up all 7 timepoints over 36 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a peer support intervention to help Latinx and Black immigrants and refugees cope with mental health, financial, and stress-related problems caused by the COVID-19 pandemic.

Who is the study for?
This trial is for Latinx immigrants and African refugees aged 18 or older living in New Mexico. It's not open to those who've used certain community services within the last year or have severe mental illness that prevents group participation.
What is being tested?
The study tests a peer advocacy and social support program called Refugee and Immigrant Well-being Project, aiming to improve mental health, financial stability, and reduce stress among Latinx and Black communities affected by COVID-19.
What are the potential side effects?
Since this intervention involves social support rather than medication, there are no direct medical side effects. However, discussing sensitive topics may cause emotional discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~all 7 timepoints over 36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and all 7 timepoints over 36 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Daily Stressors
Economic Precarity
Physical Health
+1 more
Secondary study objectives
Access to Resources
Cultural Connectedness
Discrimination
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Refugee & Immigrant Well-being Project (RIWP) InterventionExperimental Treatment1 Intervention
6-month mental health intervention that pairs university students with newcomers to engage in mutual learning, resource mobilization, and social change efforts
Group II: Treatment-as-usual Waitlist Control GroupActive Control1 Intervention
participants recruited from community-based organizations receive usual services from community-based organizations and may participate in RIWP intervention in Year 3
Group III: Random Sample of Latinx ImmigrantsActive Control1 Intervention
random sample comparison group of Latinx immigrants who are NOT randomly assigned to a treatment condition

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor
384 Previous Clinical Trials
3,524,742 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,738,753 Total Patients Enrolled
11 Trials studying Mental Health Disorders
2,860 Patients Enrolled for Mental Health Disorders

Media Library

Refugee and Immigrant Well-being Project (RIWP) Clinical Trial Eligibility Overview. Trial Name: NCT05092542 — N/A
Mental Health Disorders Research Study Groups: Treatment-as-usual Waitlist Control Group, Refugee & Immigrant Well-being Project (RIWP) Intervention, Random Sample of Latinx Immigrants
Mental Health Disorders Clinical Trial 2023: Refugee and Immigrant Well-being Project (RIWP) Highlights & Side Effects. Trial Name: NCT05092542 — N/A
Refugee and Immigrant Well-being Project (RIWP) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05092542 — N/A
~215 spots leftby Jul 2025